PHT Continues to Break ePRO Industry Records with 26 New Clinical Trials in Q3.Bookings and revenues double in third quarter as ePRO opens new eClinical possibilities CHARLESTOWN, Mass. -- PHT PHT Phenytoin (antiepileptic, Dilantin) PHT Pulmonary Hypertension PhT Pharmacy Technician PHT Post-Harvest Technology PHT Pattern History Table PHT Pressure Half Time PHT Public Health Trust Corporation, the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 250 clinical trials worldwide, today announced the results of the company's best quarterly financial performance to date. During the third quarter, PHT's LogPad[R] and StudyPad[R] Systems were selected by 10 biopharmaceutical companies for use in a record 26 new studies worldwide. "With the successful completion of this quarter, PHT continues to re-write the ePRO industry's record books," said Phil Lee, PHT President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "Last year, our then-record Q3 led the exploding ePRO market with more than 20 new trials, 73% growth in bookings, the first trial in Japan, new Indic languages Indic languages, group of languages belonging to the Indo-Iranian subfamily of the Indo-European family of languages. See Indo-Iranian. , and the first use of wirelessly integrated sensors with the PHT eSense[TM] PiKo[R]. This year, we doubled both bookings and revenues from 3Q05 due to sponsors selecting our ePRO solutions for use in larger global programs with multiple trials. PHT continues to add value to the clinical trial supply chain by providing reliable data and efficient real-time trial management to our customers investigating new therapies." PHT's consistent growth leads a similar expansion reflected throughout the industry as more sponsors adopt ePRO solutions as the gold standard in studies where the voice of the patient is required to show safety and efficacy. This increase is fueled by ROI (Return On Investment) The monetary benefits derived from having spent money on developing or revising a system. In the IT world, there are more ways to compute ROI than Carter has liver pills (and for those of you who never heard of that expression, it means a lot). success stories, the FDA's PRO Draft Guidance, and intriguing in·trigue n. 1. a. A secret or underhand scheme; a plot. b. The practice of or involvement in such schemes. 2. A clandestine love affair. v. eClinical possibilities such as adaptive trial sizing, cognitive assessments and new product capabilities (e.g. configurable email alerts out of StudyWorks[TM]). ePRO enables scientific researchers to ask new questions not possible on paper, and, most importantly Adv. 1. most importantly - above and beyond all other consideration; "above all, you must be independent" above all, most especially , to trust the PRO data they receive from patients around the world. About PHT Corporation PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in over 250 clinical trials worldwide. Subjects of all ages use PHT's LogPad([R]) and StudyPad([R]) systems, in over 70 languages and 60 countries around the world, to enter and transmit nearly 10,000 electronic reports every day. This high quality and timestamped data is used by over 70 unique biopharmaceutical and medical device companies to measure the safety and efficacy of new treatments for dozens of therapeutic areas and indications including pain, asthma, allergy allergy, hypersensitive reaction of the body tissues of certain individuals to certain substances that, in similar amounts and circumstances, are innocuous to other persons. Allergens, or allergy-causing substances, can be airborne substances (e.g. , GI and CNS See Continuous net settlement. CNS See continuous net settlement (CNS). . The data is available for real-time online review by sites and sponsors through PHT StudyWorks(TM), enabling responsive subject compliance and enrollment management. PHT, the industry leader in both experience and innovation, was the first ePRO provider to implement a study in Japan, to incorporate Indic languages on an eDiary, and to wirelessly integrate measurement devices with eDiaries for an upcoming trial. Subject experiences, captured firsthand first·hand adj. Received from the original source: firsthand information. first by PHT's user-friendly ePRO systems, have been successfully used in at least six NDA (Non Disclosure Agreement) An agreement signed between two parties that have to disclose confidential information to each other in order to do business. In general, the NDA states why the information is being divulged and stipulates that it cannot be used for any submissions, with three known approvals to date. To find out why leading biopharmaceutical companies worldwide rely on PHT's ePRO solutions to improve data quality, reduce data variance and enhance trial management efficiencies, visit www.phtcorp.com. LogPad, StudyPad and PHT are registered trademarks of PHT Corporation. StudyWorks is a trademark of PHT Corporation. PiKo is a registered trademark of Ferraris Respiratory. [c] 2006 PHT Corporation |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion